Compounds > 8-bromo cyclic adenosine monophosphate

8-bromo cyclic adenosine monophosphate and Cancer of Eye

8-bromo cyclic adenosine monophosphate has been researched along with Cancer of Eye in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chader, GJ; Gaudet, SJ; Hayden, BJ; Namboodiri, MA1
Albini, A; Aluigi, MG; Cai, T; Fassina, G; Gentleman, S; Noonan, DM; Wong, P1

Other Studies

2 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Cancer of Eye

ArticleYear
Differential regulation of arylamine and arylalkylamine N-acetyltransferases in human retinoblastoma (Y-79) cells.
    Neurochemistry international, 1993, Volume: 22, Issue:3

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Arylamine N-Acetyltransferase; Bucladesine; Butyrates; Butyric Acid; Eye Neoplasms; Humans; Retinoblastoma; Tumor Cells, Cultured

1993
The cAMP analog 8-Cl-cAMP inhibits growth and induces differentiation and apoptosis in retinoblastoma cells.
    International journal of cancer, 1997, Sep-17, Volume: 72, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Apoptosis; Bucladesine; Cell Differentiation; Cell Division; Child; Cyclic AMP-Dependent Protein Kinases; DNA Fragmentation; Eye Neoplasms; Humans; Kinetics; Macromolecular Substances; Phosphopyruvate Hydratase; Retinoblastoma; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured

1997